Elevation of serum galectin-3 and liver stiffness measured by transient elastography in biliary atresia

European Journal of Pediatric Surgery

Volumn 21, Issue 4, 2011, Pages 250-254

  Honsawek, S ^a   Chongsrisawat, V ^a   Praianantathavorn, K ^a   Theamboonlers, A ^a   Poovorawan, Y ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

biliary atresia; galectin 3; jaundice; liver stiffness; portal hypertension

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; GALECTIN 3;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILE DUCT ATRESIA; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELASTOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JAUNDICE; LIVER DISEASE; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; SCHOOL CHILD; TRANSIENT ELASTOGRAPHY;

ALANINE TRANSAMINASE; BILIARY ATRESIA; BILIRUBIN; BIOLOGICAL MARKERS; CHILD; ELASTICITY IMAGING TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALECTIN 3; HUMANS; HYPERTENSION, PORTAL; JAUNDICE; LIVER; MALE; PORTOENTEROSTOMY, HEPATIC;

EID: 80051800592     PISSN: 09397248     EISSN: 1439359X     Source Type: Journal    
DOI: 10.1055/s-0031-1273776     Document Type: Article

References (28)

1. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009 374 1704-1713
2. Bassett MD, Murray KF. Biliary atresia: recent progress. J Clin Gastroenterol 2008 42 720-729
3. Erlichman J, Hohlweg K, Haber BA. Biliary atresia: how medical complications and therapies impact outcome. Expert Rev Gastroenterol Hepatol 2009 3 425-434
4. A-Kader HH, Abdel-Hameed A, Al-Shabrawi M et al, Is biliary atresia an autoimmune disease? Eur J Gastroenterol Hepatol 2003 15 447
5. Barondes SH, Castronovo V, Cooper DN et al, Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994 76 597-598 (Pubitemid 24070645)
6. Kasai K, Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J Biochem 1996 119 1-8 (Pubitemid 26048050)
7. Liu FT. Molecular biology of IgE-binding protein, IgE-binding factors, and IgE receptors. Crit Rev Immunol 1990 10 289-306
8. Inohara H, Akahani S, Raz A. Galectin-3 stimulates cell proliferation. Exp Cell Res 1998 245 294-302 (Pubitemid 28565771)
9. Inohara H, Raz A. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res 1995 55 3267-3271
10. Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 1996 93 6737-6742 (Pubitemid 26230379)
11. Henderson NC, Sethi T. The regulation of inflammation by galectin-3. Immunol Rev 2009 230 160-171
12. Maeda N, Kawada N, Seki S et al, Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J Biol Chem 2003 278 18938-18944 (Pubitemid 36799277)
13. Lok DJ, Van Der Meer P, de la Porte PW et al, Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 2010 99 323-328
14. Wang L, Friess H, Zhu Z et al, Galectin-1 and galectin-3 in chronic pancreatitis. Lab Invest 2000 80 1233-1241 (Pubitemid 30637063)
15. Nishi Y, Sano H, Kawashima T et al, Role of galectin-3 in human pulmonary fibrosis. Allergol Int 2007 56 57-65 (Pubitemid 46449664)
16. Henderson NC, Mackinnon AC, Farnworth SL et al, Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 2008 172 288-298 (Pubitemid 351282017)
17. Kongtawelert P, Ghosh P. A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique. Anal Biochem 1990 185 313e8
18. Wai CT, Greenson JK, Fontana RJ et al, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 518-526 (Pubitemid 36919874)
19. Chongsrisawat V, Vejchapipat P, Poovorawan Y. Serum vascular endothelial growth factor per platelet count in patients with biliary atresia. Asian Biomed 2010 4 223-229
20. Chayanupatkul M, Honsawek S, Vejchapipat P et al, Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia. Eur J Pediatr Surg 2009 19 246-250
21. Honsawek S, Chongsrisawat V, Vejchapipat P et al, Association of serum levels of tissue inhibitors of metalloproteinase-1 with clinical outcome in children with biliary atresia. Asian Pac J Allergy Immunol 2006 24 161-166 (Pubitemid 44741145)
22. Honsawek S, Chongsrisawat V, Vejchapipat P et al, Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr Surg Int 2005 21 73-77 (Pubitemid 40248254)
23. Matsuda Y, Yamagiwa Y, Fukushima K et al, Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma. Hepatol Res 2008 38 1098-1111
24. Hsu DK, Dowling CA, Jeng KC et al, Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 1999 81 519-526 (Pubitemid 29203046)
25. Henderson NC, Mackinnon AC, Farnworth SL et al, Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 2006 103 5060-5065
26. Butscheid M, Hauptvogel P, Fritz P et al, Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease. J Clin Pathol 2007 60 415-418 (Pubitemid 46596562)
27. Inufusa H, Nakamura M, Adachi T et al, Role of galectin-3 in adenocarcinoma liver metastasis. Int J Oncol 2001 19 913-919
28. Shimonishi T, Miyazaki K, Kono N et al, Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum Pathol 2001 32 302-310 (Pubitemid 32246805)